Clinical trials: Recurrent Ischemic Stroke
Stroke, Cardiovascular
Home-Based SolUtion for Remote Atrial Fibrillation Screening to PrevenT RecUrrence StrOke (HUA-TUO AF Trial)
Stroke remains the leading cause of mortality and morbidity worldwide. Patients surviving the first ever stroke remain at high risk of stroke recurrence.
- Trial name
- HUA-TUO (NCT04523649)
- Testing
- Remote atrial fibrillation screening with handheld single lead ECG recorder
- Volunteers
- 1,740 people
- Sponsor
- The University of Hong Kong